Experimental and therapeutic medicine

Ginsenoside Rg1 helps protect stem cells from aging caused by gamma-ray radiation by controlling cell survival and antioxidant pathways

Updated

Abstract

Rg1 treatment significantly increased white blood cell, red blood cell, and platelet counts in peripheral blood compared with the γ-ray irradiation group (P<0.05).

  • Rg1 treatment reduced the senescence of hematopoietic stem cells and progenitor cells in aging mice exposed to γ-ray irradiation.
  • The percentage of stained cells indicating senescence was significantly lower in the Rg1 group compared to the γ-ray irradiation group (P<0.05).
  • Rg1 treatment resulted in a significant increase in mixed hematopoietic progenitor cell colony counts compared to the γ-ray irradiation group (P<0.05).
  • Levels of key proteins and mRNA associated with cellular health, such as SIRT1, SIRT3, FOXO3, and SOD2, were significantly elevated in the Rg1 group (P<0.05).
  • The proportion of stem cells in the G1 phase of the cell cycle was significantly lower in the Rg1 group compared to the γ-ray irradiation group (P<0.05).

Simplified

Full Text

We can’t show the full text here under this license.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free